TrialAlimentary pharmacology & therapeutics2023

Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST).

Henry P Parkman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.